EntryPoint Capital’s Larimar Therapeutics LRMR Stock Holding History

EntryPoint Capital’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$200K	Sell	44,479 -8,842	-17%	-$35.3K	0.06%	647
2025 Q4	$203K	Buy	+53,321	New	+$207K	0.08%	548
2025 Q1	–	Sell	-54,281	Closed	-$210K	–	837
2024 Q4	$210K	Buy	54,281 +36,045	+198%	+$238K	0.09%	576
2024 Q3	$119K	Buy	+18,236	New	+$147K	0.07%	544
2024 Q2	–	Sell	-13,927	Closed	-$106K	–	1306
2024 Q1	$106K	Buy	+13,927	New	+$109K	0.09%	392

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return